<> "The repository administrator has not yet configured an RDF license."^^ . <> . . . "NEW-GENERATION ANTICONVULSANTS IN EPILEPSY: PRACTICAL SELECTION AND SAFETY MONITORING"^^ . "Epilepsy is a chronic neurological disorder characterized by recurrent seizures. The main goals of treatment are to control seizures, minimize adverse effects, and improve patients' quality of life. In recent years, new-generation antiseizure medicines (ASMs) - brivaracetam, lacosamide, perampanel, cenobamate, cannabidiol, and fenfluramine - have stood out due to diversification of mechanisms and additional clinical options in some pharmacoresistant cases. This article, using an evidence-informed review approach, summarizes indications, efficacy signals, drug-drug interactions, and principles of safety monitoring for these agents. The findings suggest that new-generation ASMs are most often used as add-on therapy; optimal outcomes depend on patient-centered selection tailored to seizure type/syndrome, age and comorbidities, potential drug-drug interactions, and titration rate. In practice, targeted monitoring of treatment retention (persistence), cognitive and psychobehavioral effects, fall risk, and relevant laboratory indicators improves medication safety."^^ . "2026-02-02" . . . "Center for Tech and Media Research"^^ . . . "Multidisciplinary Journal of Science and Technology"^^ . . . . . . . . . . "Eshqobilov"^^ . "Ozodbek"^^ . "Eshqobilov Ozodbek"^^ . . "Choriyev"^^ . "Shohjahon"^^ . "Choriyev Shohjahon"^^ . . . . . . "NEW-GENERATION ANTICONVULSANTS IN EPILEPSY: PRACTICAL SELECTION AND SAFETY MONITORING (PDF)"^^ . . . "main.bin"^^ . . . "13655.pdf"^^ . . "HTML Summary of #65490 \n\nNEW-GENERATION ANTICONVULSANTS IN EPILEPSY: PRACTICAL SELECTION AND SAFETY MONITORING\n\n" . "text/html" . .